Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 16, 2012
Evotec AG and IR Pharma today announced that they have entered into an exclusive strategic alliance to provide integrated drug discovery solutions to Pharmaceutical and Biotech companies in the field of Respiratory Diseases.
read more
Thursday, November 10, 2016
Evotec AG has announced a novel strategic partnership with the University of Oxford, Oxford University Innovation Ltd, OUI (the university's research commercialization company) and Oxford Sciences Innovation, OSI (the world's largest IP investment ...
read more
Evotec has announced a multi-year compound management agreement with Pierre Fabre Laboratories, the second largest private French pharmaceutical group.
read more
Evotec AG has announced a collaboration with UCB to provide a broad range of in vitro pharmacology services.
read more
Evotec AG announced it will make a strategic investment as part of Facio Therapies' 2017 funding round together with the Facioscapulohumeral dystrophy community.
read more
Evotec AG has announced a collaboration with Antibiotic Research UK to identify alternative means of treating infections that are resistant to currently available antibiotics.
read more
Evotec AG announced has successfully completed the acquisition of Aptuit as announced in detail on 30 July 2017.
read more
Evotec announced an integrated drug discovery collaboration with STORM Therapeutics to develop new small molecule epigenetic drugs for oncology and other therapeutic areas.
read more
Evotec AG today announced that it has expanded the scope of its collaboration with MedImmune, the global biologics arm of AstraZeneca, after hitting a key milestone. Evotec achieved a milestone payment of EURO0.5 m. The milestone triggers a ...
read more
Wednesday, April 11, 2018
Evotec AG announced a strategic collaboration with Petra Pharma Corporation.
read more
Evotec has launched its accelerated drug development service INDiGO.
read more
Evotec AG has been awarded a grant for a period of two years from IFB Hamburg to identify and develop therapeutic antibodies directed against novel immune-checkpoints on T-cells to improve future cancer treatments.
read more
Evotec AG today announced that its research alliance with Boehringer Ingelheim has reached a milestone triggering a payment of EUR 4.0 million to Evotec. The milestone was for the transition of a respiratory programme into pre-clinical development.
read more
Evotec AG today announced that its research alliance with Boehringer Ingelheim has reached a milestone in June triggering revenues of EUR 1.5 m to Evotec. The milestone was for the transition of a pain molecule into pre-clinical development.
read more
Evotec AG announced its multi-target endometriosis alliance with Bayer has reached another significant pre-clinical milestone, triggering a payment of approx. EUR 5 m to Evotec for the transition of a program into pre-clinical development for the ...
read more